Healio

Micropulse transscleral cyclophotocoagulation may lower IOP in pediatric patients

Please provide your email address to receive an email when new articles are posted on . Micropulse transscleral cyclophotocoagulation lowered IOP in pediatric patients with refractory glaucoma, ...
Nasdaq

MicroPulse® Transscleral Laser Therapy Will be Discussed in Various Presentations and Educational Events at ESCRS 2019 in Paris, France

MOUNTAIN VIEW, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal ...
Healio

Study investigates predictors of success for diode laser cyclophotocoagulation in glaucoma

Please provide your email address to receive an email when new articles are posted on . Higher baseline IOP and a history of cataract extraction were found to be predictors of success in a cohort of ...
Nasdaq

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

MOUNTAIN VIEW, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...
National Institute for Health and Care Excellence

Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma

Glaucoma is usually a chronic condition associated with raised intraocular pressure. The most common type of glaucoma in the UK is primary (or chronic) open-angle glaucoma. It leads to progressive ...